All antibodies are NOT created equal: Comprehensive profiling of SARS-CoV-2 antibodies
In this webinar, we will discuss:
- Understand the drawbacks of standard immunoassays such as ELISA tests
- Understand that affinity-based antibody profiling is key for a comprehensive understanding of the immune response against SARS-CoV-2
- Learn about the ability to assess the immune response of COVID-19 patients directly in minimally diluted serum by use of a novel in-solution immunoassay platform
- Understand how this technology can be leveraged by scientists in the fight against COVID-19
You can find out more and save your spot by registering here
Fluidic Analytics envisions a world where information about proteins and their behaviour transforms our understanding of how the biological world operates. By building the world’s best tools, software and services for protein characterisation and making them universally accessible in the lab, in the clinic or at home, we are making this vision a reality not just for a small group of expert users, but for everyone who can benefit.